Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum

Learn more about:
Related Clinical Trial
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2) Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients The Effect of “Jinchuang Ointment” (JCO) on the Treatment of Wounds in Patients With Hansen’s Disease. Ciclosporin in the Management of New Erythema Nodosum Leprosum Effect of Weight and/or Obesity on Dapsone Drug Concentrations Treatment of Neuropathic Pain in Leprosy Montelukast in ENL Reaction Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients Molecular and Immunological Tools for Detection of Strain Diversity, Drug Resistance and Immunological Responses Ciclosporin in the Management of New Type 1 Reactions in Leprosy Uniform Multidrug Therapy Regimen for Leprosy Patients Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar Improved Understanding of Ongoing Transmission of Leprosy in the Hyperendemic Comoros (ComLep) Molecular Epidemiology of Leprosy – Philippines Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients Leprosy Skin Test Antigens Phase 1

Recruitment Information


Administrative Informations